BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Horizon Pharma Has Commenced Solicitation Of Depomed Shareholders For Calling Of Special Meetings

  September 14, 2015

   · 

  12 min read
• Drug Development

  Lion Pharmaceuticals, Inc. Opens Enrollment In Phase 2 Study Of LN-144 For The Treatment Of Refractory Metastatic Melanoma

  September 14, 2015

   · 

  3 min read
• Drug Development

  Theravance Biopharma And Mylan Initiate Phase 3 Program For Revefenacin (TD-4208) For Treatment Of Chronic Obstructive Pulmonary Disease (COPD)

  September 14, 2015

   · 

  11 min read
• Pharm Country

  Arno Therapeutics Release: AR-12 Abstracts Accepted For Podium Presentation And Three Posters At ICAAC/ICC Annual Meeting 2015

  September 14, 2015

   · 

  5 min read
• Pharm Country

  PIN Pharma To Present A Poster At AACR Inaugural International Cancer Immunotherapy Conference, Translating Science Into Survival 2015

  September 14, 2015

   · 

  1 min read
• Lone Star Bio

  Celanese Presents Advancements In Pharmaceutical Controlled Release At Polymers In Medicine And Biology Conference

  September 14, 2015

   · 

  1 min read
• BioForest

  Seattle Genetics Announces Exercise Of Over-Allotment Option

  September 14, 2015

   · 

  1 min read
• BioCapital

  Eli Lilly to Host Site Partnership Symposium at Global Site Solutions Summit

  September 14, 2015

   · 

  2 min read
• Biotech Bay

  BioTime Agrees To Sell $8.58 Million Of Common Shares

  September 14, 2015

   · 

  1 min read
• Business

  Vygon Opens Turkish Subsidiary

  September 14, 2015

   · 

  4 min read